Resmetirom Patent Expiration

Resmetirom is Used for treating adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis. It was first introduced by Madrigal Pharmaceuticals Inc in its drug Rezdiffra on Mar 14, 2024.


Resmetirom Patents

Given below is the list of patents protecting Resmetirom, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Rezdiffra US10376517 Methods of synthesizing thyroid hormone analogs and polymorphs thereof Sep 17, 2033 Madrigal
Rezdiffra US11564926 Methods of synthesizing thyroid hormone analogs and polymorphs thereof Sep 17, 2033 Madrigal
Rezdiffra US7452882 Thyroid hormone analogs Sep 12, 2026 Madrigal
Rezdiffra US9266861 Method of synthesizing thyroid hormone analogs and polymorphs thereof Sep 17, 2033 Madrigal


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳